Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs
Status:
Completed
Trial end date:
2004-11-29
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
investigate the effectiveness of biphasic insulin aspart 30 in type 2 diabetics not achieving
blood sugar levels when treated with oral anti-diabetics drugs (OADs) with or without basal
insulin therapy.